Very rare adverse reactions to intravascular contrast media: From Kounis to sweet syndrome DOI Creative Commons
Aart J. van der Molen, José Julio Laguna, Annick van de Ven

et al.

European Journal of Radiology, Journal Year: 2025, Volume and Issue: unknown, P. 112066 - 112066

Published: March 1, 2025

Intravascular administration of contrast media may inadvertently result in adverse drug reactions (ADR) including selected hypersensitivity reactions. This review highlights some very rare ADR, aiming to alert imaging physicians these conditions and prompt adequate management. is particularly relevant for Kounis syndrome, an immediate reaction involving the coronary arteries. The acute management syndrome can be challenging, as it requires continued administration, while balancing simultaneous reperfusion that vasodilatation with anti-allergic treatment involve vasoconstrictor agents. For other reactions, referral a allergy specialist highly recommended assess causality identify safe alternatives. CLINICAL RELEVANCE STATEMENT: Cardiologists radiologists must recognize key symptoms promptly initiate appropriate therapy refer patients allergological evaluation, ideally within 1-6 months after reaction.

Language: Английский

Very rare adverse reactions to intravascular contrast media: From Kounis to sweet syndrome DOI Creative Commons
Aart J. van der Molen, José Julio Laguna, Annick van de Ven

et al.

European Journal of Radiology, Journal Year: 2025, Volume and Issue: unknown, P. 112066 - 112066

Published: March 1, 2025

Intravascular administration of contrast media may inadvertently result in adverse drug reactions (ADR) including selected hypersensitivity reactions. This review highlights some very rare ADR, aiming to alert imaging physicians these conditions and prompt adequate management. is particularly relevant for Kounis syndrome, an immediate reaction involving the coronary arteries. The acute management syndrome can be challenging, as it requires continued administration, while balancing simultaneous reperfusion that vasodilatation with anti-allergic treatment involve vasoconstrictor agents. For other reactions, referral a allergy specialist highly recommended assess causality identify safe alternatives. CLINICAL RELEVANCE STATEMENT: Cardiologists radiologists must recognize key symptoms promptly initiate appropriate therapy refer patients allergological evaluation, ideally within 1-6 months after reaction.

Language: Английский

Citations

0